Nuwellis, Inc.
NUWE- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001506492
No open-market purchases or sales by Nuwellis, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $63.9K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Nuwellis, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 11 | 9 | −2 |
| Shares | 138.3K | 327.3K | +189.0K (+136.7%) |
| Value | $128.6K | $72.1K | −$56.5K (−43.9%) |
New holders (2)
Institutions that held Nuwellis, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 147,961 | $32.6K | 0.25% |
| Morgan Stanley | 5,310 | $1.17K | 0.00% |
Sold out (4)
Institutions that held Nuwellis, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Virtu Financial LLC | 27,080 | $25.0K |
| Citadel Advisors LLC | 19,538 | $18.4K |
| HRT Financial LP | 10,550 | $9.00K |
| JPMorgan Chase & Co | 1 | $1 |